PROC PROCAPS GRP SA

Procaps Group to Participate in the BTG Pactual LatAm CEO Conference

Procaps Group to Participate in the BTG Pactual LatAm CEO Conference

MIAMI and BARRANQUILLA, Colombia, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced it will participate in the BTG Pactual LatAm CEO Conference being held at the InterContinental NY Barclays Hotel October 11-13, 2022.

Procaps Group Chief Executive Officer Rubén Minski, Chief Financial Officer Patricio Vargas, and Investor Relations Director Melissa Angelini will conduct in-person one-on-one meetings on October 11 and 12 during which they will discuss the pending acquisition of Grupo Somar, 2022 performance, and other strategic initiatives.

BTG Pactual LatAm CEO Conference

Date: October 11-13, 2022

Location: New York, NY

Format: In-person 1x1's and presentation

Attendees: Chief Executive Officer Rubén Minski, Chief Financial Officer Patricio Vargas, Investor Relations Director Melissa Angelini

For more information on the BTG Pactual LatAm CEO Conference or to schedule a one-on-one meeting with Procaps Group management, please contact your conference representative or you may also email your request to .

About Procaps Group

Procaps Group, S.A. (“Procaps”) (NASDAQ: PROC) is a leading developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 5,300 employees working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) pharmaceutical products, prescription pharmaceutical drugs (Rx), nutritional supplements, and high-potency clinical solutions.

For more information, visit or Procaps’ investor relations website .

Investor Contact:

Melissa Angelini





 



EN
05/10/2022

Underlying

PROCPROCAPS GRP SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PROCAPS GRP SA

 PRESS RELEASE
Free
PROC PROCAPS GRP SA

Procaps Group Secures $130 Million in Equity Investment and Completes ...

Procaps Group Secures $130 Million in Equity Investment and Completes Comprehensive Debt Restructuring, as New Investors Take Over Strategic Leadership New Investors Take Over the Strategic Leadership as Headquarters Move to Bogotá, Marking the Start of a New Chapter of Growth, Execution, and Transformation under Enhanced Governance Company Accelerates Turnaround with Leadership Changes, Regional Realignment, Sale of Non-Core Assets and Renewed Governance MIAMI and BOGOTA, Colombia, April 09, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (“Procaps” or the “Company”), a leading Latin Amer...

April 9, 2025 1 EN
 PRESS RELEASE
Free
PROC PROCAPS GRP SA

Procaps Group Receives Delisting Notice From Nasdaq

Procaps Group Receives Delisting Notice From Nasdaq MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) that it has determined to delist the Company’s ordinary shares on Nasdaq. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5250(c)(1) and 5250(c)(2) for failing to file periodic and inte...

February 3, 2025 1 EN
 PRESS RELEASE
Free
PROC PROCAPS GRP SA

Procaps Group Receives Additional Delinquency Letter

Procaps Group Receives Additional Delinquency Letter MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that, as anticipated, on December 31, 2024, the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) of an additional filing delinquency relating to the Company’s interim financial statements for the period ended June 30, 2024. The interim financial statements were required to be filed with Nasdaq by ...

January 3, 2025 1 EN
 PRESS RELEASE
Free
PROC PROCAPS GRP SA

Procaps Group Announces Key Shareholder and Board Decisions, Committee...

Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced significant outcomes from its recent Shareholders Meeting and subsequent Board of Directors meeting. These include changes to the Board composition, restructuring of Board committees, and updates to its executive leadership team. The Shareholders Meeting ma...

December 20, 2024 1 EN
 PRESS RELEASE
Free
PROC PROCAPS GRP SA

Procaps Issues Shareholder Letter Update

Procaps Issues Shareholder Letter Update MIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services, today issued the below letter to shareholders from José Antonio Vieira, CEO of Procaps, providing critical updates on the Company’s ongoing independent investigation, financial restatement, governance enhancements, and commitment to long-term stability. “Dear Shareholders, As we navigate recent challenges at Procaps, I want to personally reaffirm...

October 10, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch